Health Results Based Financing Impact Evaluation 2021 -2022, Health Facility Follow-Up Survey
Congo, Dem. Rep., 2021 - 2022
Get MicrodataCreated on
May 30, 2023
Last modified
May 30, 2023
Page views
79370
Downloads
881
[F2_1507c] Troisième médicament (f2_1507c)
Data file: f2_providers_anon
Overview
Valid:
14
Invalid:
1444
Minimum:
1
Maximum:
97
Type:
Discrete
Decimal:
0
Width:
12
Range:
1 - 97
Format:
Numeric
Questions and instructions
Categories
| Value | Category | Cases | |
|---|---|---|---|
| 1 | favipiravir | 1 |
0.1%
|
| 2 | nitazoxanide | 1 |
0.1%
|
| 4 | chloroquine | 1 |
0.1%
|
| 6 | promothazine | 2 |
0.1%
|
| 7 | lopinavir | 1 |
0.1%
|
| 8 | cyclosporine | 1 |
0.1%
|
| 97 | autre | 7 |
0.5%
|
| Sysmiss | 1444 |
99%
|
Warning: these figures indicate the number of cases found in the data file. They cannot be interpreted as summary statistics of the population of interest.